Professor Zoë Winters

University College London
Consultant Oncoplastic Breast Surgeon & Honorary Professor of Surgery

Zoë Is an Honorary Professor of Breast Surgery at University College London (UCL) and has practiced as a Senior Consultant Onncoplastic Breast Surgeon since 2000. She practiced at the University Hospital Bristol until November 2016, subsequently re-locating to London. She trained at leading University Hopsitals in Johannesburg and Cape Town, South Africa before receiving the Oxford Nuffield Senior Research Fellowship to complete her PhD in Molecular Biology at the University of Oxford, Worcester College with the world leading Medical Oncologist Professor Adrian Harris. Zoë was awarded the Royal College of Surgeons of Edinburgh King James IV Professorship for her contributions to Surgery Research in 2001. Zoë was awarded an Honorary Chair in Surgery at University College London working with the Surgery Interventional Trials Unit in the Department of Surgery and Interventional Science in 2017. She has run two world first breast cancer clinical trials working with UCL where she currently leads her clinical academic research.

dont miss

Is breast conserving surgery a future treatment for multiple ipsilateral breast cancers?

Can patients with multiple breast cancers in the same breast avoid mastectomy by having multiple lumpectomies to achieve equivalent rates of local breast cancer recurrence?

Study protocol for a randomised controlled feasibility trial (UK MIAMI)

Professor Zoë Winters will be speaking in the following theatre:

Theatre 11 - Wednesday 13.15 - 13.45: Is breast conserving surgery a future treatment for multiple ipsilateral breast cancers?

EVEN MORE SEMINARS

  • Martyn Kennedy: Speaking at the Oncology Convention

    Martyn Kennedy
    Leeds Teaching Hospitals NHS Trust

    The Yorkshire Lung Screening Trial (YLST)

  • Mr Richard Steyn: Speaking at the Oncology Convention

    Mr Richard Steyn
    UK Lung Cancer Coalition / University Hospitals Birmingham NHS Foundation Trust

    Doubling Five-Year UK Lung Cancer Survival to 25% by 2025

  • Professor Hisham Mehanna: Speaking at the Oncology Convention

    Professor Hisham Mehanna
    InHANSE, Institute of Cancer and Genomic Sciences, University of Birmingham

    Clinical trials that change patient care and the lessons learnt

  • Luca Boldrini: Speaking at the Oncology Convention

    Luca Boldrini
    Università Cattolica del Sacro Cuore, Roma, Italia

    Radiomics applications rectal cancer: the MRIdian perspective

  • Stuart Dollow: Speaking at the Oncology Convention

    Stuart Dollow
    Vermilion Life Sciences Ltd

    Reengineering Medicines Development